Alnylam Pharmaceuticals | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 32.37M 13.08M 2025-06
Agios Pharmaceuticals USD -127056000 20.43M 2025-06
Alnylam Pharmaceuticals USD -16199000 34.28M 2025-06
Amgen USD 2.66B 1.37B 2025-06
Arrowhead Research USD -165550000 546.75M 2025-06
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
Incyte USD 310.82M 105.66M 2025-06
Ionis Pharmaceuticals USD 139.84M 285.84M 2025-06
Moderna USD -907000000 143M 2025-06
Neurocrine Biosciences USD 145.6M 121.9M 2025-06
Novartis USD 3.4B 193M 2024-12
PTC Therapeutics USD -34858000 1.01B 2025-06
Regeneron Pharmaceuticals USD 1.08B 487.8M 2025-06
Sanofi EUR 861M 2.77B 2024-12
Sarepta Therapeutics USD 115.58M 415.96M 2025-06
Takeda JPY 184.56B 259.5B 2025-06
Tectonic Therapeutic USD -13991000 5.65M 2024-12
Ultragenyx Pharmaceutical USD -193567000 50.63M 2025-06
Vertex Pharmaceuticals USD 1.15B 123.1M 2025-06
Xencor USD -33172000 10.01M 2025-06


Alnylam Pharmaceuticals Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.